eSight™ assistive device for the visually impaired available for demonstration at Canadian Business Journal’s AAO

CHICAGO, Sept. 20, 2022 (GLOBE NEWSWIRE) — Cutting Edge Vision Enhancement Platform, eSightholds demonstrations of current medical device models. eSight4, American Academy of Ophthalmology Conference September 30-October 3, 2022, Chicago, Illinois.

eSight 4 is a clinically validated, FDA registered low vision device designed to help patients with central vision loss achieve up to 20/20 vision. It works by stimulating synaptic neural activity in the remaining photoreceptor function of the patient’s eye to provide increased visual information to the brain. The patented Bioptic Tilt Technology enables a partially sighted user to use their peripheral vision for greater mobility when using his eSight on the go. Users can wear the device at home, work, school, or while out with friends and family. eSight uses cutting-edge technology to help the visually impaired and legally blind, and with the eSight Telehealth program, welcomes new users wherever they live.

Recent technological advances have enabled a switch to full or hybrid telemedicine models. This model allows physicians to quickly re-evaluate and redirect, allowing patients with low vision to evaluate eSight in a real-world setting, minimizing the potential burden on referral clinics and saving patient time. Save money, save money on travel, and ensure increased patient satisfaction and follow-up adherence. eSight’s telemedicine program allows qualified users to try out her eSight device in the comfort of their own home. After booking an appointment time for an evaluation session, eSight ships her eSight 4 device directly to the patient’s home. Upon arrival, an eSight specialist will walk the patient through setup and calibration for the best possible visual results. Patients can test the device for several days to determine the best fit.

“Our industry has seen significant changes in telemedicine capabilities since the onset of the COVID pandemic, and it is up to us to maintain that momentum for the health and well-being of our patients,” said eSight. Roland Matern, Director of Product Marketing, said. “We are at a time when technology can easily transform the lives of blind people with the click of a button. Creating, maintaining and improving robust telemedicine systems for people with eye diseases.” This fall, we will have eye care professionals learn about telehealth programs and experience life-changing eSight devices.”

Gary Foster, a longtime user of low vision devices, will be at the eSight booth to talk about his own experience finding eSight and the importance of early referral of patients for vision loss. Over the last year, eSight has expanded its sales network to eye care professionals and government agencies in North America and Western Europe.

To see a demonstration of eSight 4, visit eSight at Booth 1726 at the AAO. www.eSightEyewear.com.

About eSight
eSight, the leading vision platform organization, has a simple but profound promise. It is about enabling blind people to see new possibilities through enhanced vision. eSight offers the most advanced and versatile assistive device available for the visually impaired, addressing over 20 eye conditions including macular degeneration, diabetic retinopathy and Stargardt’s disease. eSight is FDA and EUDAMED registered and tested by Health Canada.Click here for details www.eSightEyewear.com.

eSight Media Contacts
melanie du mont
eSight riot PR
[email protected]
(321) 236-0102

CBJ Newsmaker